SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Rani Therapeutics Holdings, Inc.
Date: July 9, 2025 · CIK: 0001856725 · Accession: 0001193125-25-157074

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-288509

Date
July 9, 2025
Author
Svai Sanford
Form
CORRESP
Company
Rani Therapeutics Holdings, Inc.

Letter

July 9, 2025 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 RE: Rani Therapeutics Holdings, Inc. Registration Statement on Form S-3 File No. 333-288509 Ladies and Gentlemen: Rani Therapeutics Holdings, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on July 11, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059.

Very truly yours,
RANI THERAPEUTICS HOLDINGS, INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 July 9, 2025
 United States Securities and Exchange Commission Division of
Corporation Finance 100 F Street, N.E. Washington, D.C.
20549 RE:    Rani Therapeutics Holdings, Inc.
 Registration Statement on Form S-3
 File No. 333-288509
 Ladies and Gentlemen: Rani Therapeutics
Holdings, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on
Form S-3 to become effective on July 11, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the
staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
 Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to
the Registrant, at (650) 843-5059.

 Very truly yours,

 RANI THERAPEUTICS HOLDINGS, INC.

 By:

 /s/ S VAI S ANFORD

 Name:

 Svai Sanford

 Title:

 Chief Financial Officer

 cc:
 John T. McKenna, Cooley LLP